Magnus Financial Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.72M | Buy |
6,845
+51
| +0.8% | +$11K | 0.12% | 113 |
|
|
2026
Q1 | $1.48M | Buy |
6,794
+54
| +0.8% | +$12K | 0.12% | 121 |
|
|
2025
Q4 | $1.54M | Sell |
6,740
-152
| -2% | -$34.6K | 0.12% | 135 |
|
|
2025
Q3 | $1.6M | Buy |
6,892
+270
| +4% | +$55K | 0.13% | 130 |
|
|
2025
Q2 | $1.23M | Buy |
6,622
+41
| +0.6% | +$7.62K | 0.11% | 145 |
|
|
2025
Q1 | $1.38M | Buy |
6,581
+104
| +2% | +$20.2K | 0.13% | 120 |
|
|
2024
Q4 | $1.15M | Sell |
6,477
-2,501
| -28% | -$460K | 0.11% | 139 |
|
|
2024
Q3 | $1.77M | Buy |
8,978
+829
| +10% | +$155K | 0.18% | 101 |
|
|
2024
Q2 | $1.4M | Sell |
8,149
-192
| -2% | -$31.8K | 0.16% | 105 |
|
|
2024
Q1 | $1.52M | Buy |
8,341
+890
| +12% | +$153K | 0.18% | 97 |
|
|
2023
Q4 | $1.15M | Buy |
7,451
+785
| +12% | +$114K | 0.15% | 115 |
|
|
2023
Q3 | $994K | Buy |
6,666
+37
| +0.6% | +$5.43K | 0.14% | 112 |
|
|
2023
Q2 | $893K | Buy |
6,629
+45
| +0.7% | +$6.6K | 0.13% | 121 |
|
|
2023
Q1 | $1.05M | Buy |
6,584
+231
| +4% | +$35.3K | 0.16% | 106 |
|
|
2022
Q4 | $1.03M | Buy |
6,353
+170
| +3% | +$26.1K | 0.17% | 104 |
|
|
2022
Q3 | $830K | Buy |
6,183
+358
| +6% | +$51.4K | 0.16% | 110 |
|
|
2022
Q2 | $892K | Buy |
5,825
+118
| +2% | +$18K | 0.16% | 107 |
|
|
2022
Q1 | $925K | Buy |
5,707
+284
| +5% | +$41.3K | 0.15% | 112 |
|
|
2021
Q4 | $734K | Buy |
5,423
+409
| +8% | +$48.3K | 0.14% | 110 |
|
|
2021
Q3 | $541K | Buy |
5,014
+42
| +0.8% | +$4.8K | 0.11% | 123 |
|
|
2021
Q2 | $560K | Buy |
4,972
+281
| +6% | +$31.6K | 0.12% | 109 |
|
|
2021
Q1 | $508K | Sell |
4,691
-4,601
| -50% | -$492K | 0.12% | 106 |
|
|
2020
Q4 | $996K | Sell |
9,292
-762
| -8% | -$73.2K | 0.1% | 76 |
|
|
2020
Q3 | $881K | Sell |
10,054
-5,060
| -33% | -$476K | 0.1% | 77 |
|
|
2020
Q2 | $1.48M | Sell |
15,114
-116
| -0.8% | -$10.2K | 0.16% | 52 |
|
|
2020
Q1 | $1.16M | Buy |
15,230
+10,502
| +222% | +$895K | 0.16% | 66 |
|
|
2019
Q4 | $419K | Buy |
4,728
+75
| +2% | +$6.23K | 0.06% | 182 |
|
|
2019
Q3 | $352K | Buy |
4,653
+856
| +23% | +$58.7K | 0.07% | 192 |
|
|
2019
Q2 | $276K | Buy |
3,797
+35
| +0.9% | +$2.75K | 0.05% | 293 |
|
|
2019
Q1 | $303K | Sell |
3,762
-1,153
| -23% | -$94.3K | 0.06% | 231 |
|
|
2018
Q4 | $453K | Buy |
+4,915
| New | +$432K | 0.12% | 97 |
|
Other funds holding ABBV
Magnus Financial Group's ABBV Position: Q2 2026 in Review
Magnus Financial Group increased its AbbVie (ABBV) stake by 0.75% in Q2 2026, buying an estimated $11K and bringing the position to 6,845 shares worth $1.72M. The position accounts for 0.12% of the portfolio, ranked #113.
Magnus Financial Group first reported a position in ABBV in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.77M in Q3 2024. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Magnus Financial Group held 6,845 shares of AbbVie worth $1.72M as of Q2 2026.
- Magnus Financial Group bought 51 AbbVie shares in Q2 2026, an estimated $11K.
- AbbVie made up 0.12% of Magnus Financial Group's portfolio in Q2 2026, its #113 holding.
- Magnus Financial Group first reported a position in AbbVie in Q4 2018 and has held it in 31 quarters since.
- Magnus Financial Group's AbbVie position peaked at $1.77M in Q3 2024.
- 4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Magnus Financial Group's 13F filing for Q2 2026, filed 9 Jul 2026.